At Endeavor Health, research is deeply embedded in the way we care for patients. Our cancer specialists participate in national studies and local research initiatives to expand treatment options, improve early detection and reduce side effects. Clinical trials give eligible patients access to promising new therapies before they’re widely available — offering hope, especially when other options have been exhausted.
We believe that participation in research is a powerful way to contribute to the future of cancer care while receiving expert, personalized treatment.

In addition to their involvement in clinical trials, Endeavor Health researchers are part of your multidisciplinary care team. We participate in translational research — bringing breakthroughs from the lab directly into clinical practice.
Our areas of focus include:
- Early detection and prevention
- Molecular and genomic testing
- New drug development
- Improving treatment outcomes
- Reducing side effects of standard therapies
- Expanding equity and access in cancer research
Explore clinical trials by cancer type
Each link directs to pre-filtered trials on the StudyFinder platform (or equivalent).
- Brain and spine tumors
- Breast
- Gastrointestinal (colon, esophageal, liver, pancreatic, stomach)
- Genitourinary (bladder, genital, kidney, prostate, urinary)
- Gynecologic (cervical, uterine, ovarian, vaginal)
- Head and neck (larynx, mouth, throat, thyroid)
- Hematologic (leukemia, lymphoma, myeloma)
- Lung and thoracic
- Sarcoma
- Long-term follow-up care
- Skin and melanoma
- Supportive care
- Trials inclusive of all cancers
- Developmental Therapeutics/ new drugs
Latest insights in cancer care




The Endeavor Health Cancer Institute delivers cutting-edge cancer care backed by research, technology and a collaborative commitment to continuous discovery — helping more patients benefit from tomorrow’s breakthroughs today.

